Evidence map›Paper›PMID 26873725›Full record

SynthesisChronic respiratory disease2016

Pain and its clinical associations in individuals with cystic fibrosis: A systematic review.

Annemarie L Lee, Sarah Rawlings, Katharine A Bennett, David Armstrong

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Chronic respiratory disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2021
    Pooled it
  2. Article
  3. Article
  4. Use of Buprenorphine/Naloxone in an Adult with Cystic Fibrosis.The Canadian journal of hospital pharmacy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Satisfaction and effectiveness of opioid pain management among adults with cystic fibrosis: A mixed methods study.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Sleep and Pain in Pediatric Illness: A Conceptual Review.CNS neuroscience & therapeutics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Annemarie L LeeWest Park Healthcare Centre, Toronto, Ontario, Canada Institute for Breathing and Sleep, Victoria, Australia annemarie.lee@westpark.org.
Sarah RawlingsMonash Health, Victoria, Australia.
Katharine A BennettWestern Hospital, Victoria, Australia.
David ArmstrongMonash Health, Victoria, Australia Department of Paediatrics, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Institute for Breathing and Sleep · AUMonash Health · AUMonash University · AUWestern Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain is recognized as a clinical complication in cystic fibrosis (CF), but the prevalence, characteristics and clinical associations of this co-morbidity have not been systematically reviewed. Electronic searches of six databases were performed. For inclusion in phase 1, studies reported a pain prevalence rate in CF and/or its clinical associations. For phase 2, included studies reported the measurement properties of validity, reliability and responsiveness of an instrument assessing pain in CF. Two independent reviewers rated the quality of evidence (phase 1) and the measurement properties using the 4-point COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist (phase 2). Of the 400 studies identified in the literature, 16 met the inclusion criteria for phase 1 and 5 for phase 2. The mean (SD) quality score (of 16) was 11.8 (2.3). The pooled prevalence of pain in adults with CF was 77% (95% confidence interval (CI): 57%-92%) and in children was 42% (95% CI: 0%-91%). Common regions of pain included back, abdomen, chest and limbs. In children and adults, pain was associated with a poorer quality of life (QOL) and significant interference with treatments. Measurement properties of three instruments (Brief Pain Inventory, Multidimensional Pain Inventory, Daily Pain Assessment-CF) were construct validity and criterion-predictive validity, with variable findings based on 'fair' to 'good' quality studies. Pain is a common problem in both children and adults with CF. It has negative clinical associations with QOL and the ability to successfully undertake treatment. Further research exploring the measurement properties of instruments assessing pain is required.

Indexed as

Abdominal PainAdultBack PainChest PainChildCystic FibrosisHumansMusculoskeletal PainPainPain MeasurementPrevalenceQuality of LifeReproducibility of Resultsclinical symptomsCystic fibrosismeasurementprevalence of painquality of life

Identifiers

PMID26873725
PMCPMC5734596
OpenAlexW2285861324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.